Evidence map›Paper›PMID 36321820›Full record

ArticleJournal of clinical microbiology2022

Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium.

Marie Gardette, Nadège Hénin, Chloé Le Roy, Jennifer Guiraud, Arabella Touati, Cécile Bébéar, Sabine Pereyre

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marie GardetteCHU Bordeaux, Bacteriology Department, National Reference Center for Bacterial Sexually Transmitted Infections, Bordeaux, France.
Nadège HéninUniversity of Bordeauxgrid.412041.2, CNRS, Fundamental Microbiology and Pathogenicity, UMR 5234, Bordeaux, France.
Chloé Le RoyUniversity of Bordeauxgrid.412041.2, CNRS, Fundamental Microbiology and Pathogenicity, UMR 5234, Bordeaux, France.
Jennifer GuiraudCHU Bordeaux, Bacteriology Department, National Reference Center for Bacterial Sexually Transmitted Infections, Bordeaux, France.
Arabella TouatiCHU Bordeaux, Bacteriology Department, National Reference Center for Bacterial Sexually Transmitted Infections, Bordeaux, France.
Cécile BébéarCHU Bordeaux, Bacteriology Department, National Reference Center for Bacterial Sexually Transmitted Infections, Bordeaux, France.
Sabine PereyreCHU Bordeaux, Bacteriology Department, National Reference Center for Bacterial Sexually Transmitted Infections, Bordeaux, France.ORCID 0000-0003-1757-4206
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high prevalence of macrolide resistance in Mycoplasma genitalium results in an increased reliance on moxifloxacin, the second-line treatment; however, moxifloxacin resistance has also emerged. Because assays that can detect fluoroquinolone resistance-associated mutations will be useful for the management of macrolide-resistant M. genitalium infections, we evaluated the performance of three commercial assays (the Allplex MG & MoxiR Assay [Seegene], LightMix Modular parC kit [TIBMOLBIOL], and MGMO qPCR [NYtor) in comparison with

Indexed as

Mycoplasma genitaliumMycoplasma InfectionsAnti-Bacterial AgentsDNA, BacterialDrug Resistance, BacterialFluoroquinolonesHumansMacrolidesMoxifloxacinMutationPathology, MolecularRNA, Ribosomal, 23SAnti-Bacterial AgentsDNA, BacterialFluoroquinolonesMacrolidesMoxifloxacinRNA, Ribosomal, 23Santibiotic resistancecommercial kitsdetectionfluoroquinoloneMycoplasma genitalium

Identifiers

PMID36321820
PMCPMC9769504
OpenAlexW4308061336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.